Switch to:
More From Other Websites
[$$] How Mylan Got the Market And Criticism It Deserves Sep 24 2016
Generics or Specialty: Which Mylan Segment Is Growing Fastest? Sep 23 2016
You’ve Heard about the EpiPen Debacle, but Have You Heard This? Sep 23 2016
Are Mylan’s EpiPen Challenges Souring Analysts’ Views on Stock? Sep 23 2016
Next Drug Price Scandal Could Be Cost of Naloxone Sep 23 2016
The next EpiPen? Sep 23 2016
The Zacks Friday Finish Line Highlights: IPOs, Netflix, Comcast, Wells Fargo, Mylan Sep 23 2016
Endo Int'l: New CEO "Has His Work Cut Out For Him" Sep 23 2016
5 Most Shocking Congressional Testimonies by CEOs Sep 23 2016
Wells Fargo and Mylan: Corporate Devils or Unworthy Scapegoats? Sep 23 2016
CEO Isn't All That's Under Pressure at Mylan Sep 23 2016
USA Today On EpiPen Saga: Calling It 'Controversial' Is Far From Haphazard Sep 23 2016
[$$] US politicians lament inaction over price-gouging drug companies Sep 23 2016
Even Elizabeth Warren’s fury can’t shame America’s CEOs Sep 23 2016
5 things we still don’t know about EpiPen pricing after Mylan’s congressional beating Sep 23 2016
Parent bloggers question role in Mylan's EpiPen schools push Sep 23 2016
[$$] Overheard: Firms on Hot Seat, but Shares are Steady Sep 22 2016
[$$] Overheard Sep 22 2016
Mylan CEO: Reformulating EpiPen to Have Longer Shelf Life Sep 22 2016
Mylan CEO: Reformulating EpiPen to Have Longer Shelf Life Sep 22 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK